FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007180939> ?p ?o ?g. }

• W2007180939 endingPage "526" @default.
• W2007180939 startingPage "520" @default.
• W2007180939 abstract "Rescue chemotherapy or autologous stem cell transplantation (autoSCT) gives disappointing results in relapsed peripheral T-cell lymphomas (PTCLs). We have retrospectively evaluated the long-term outcome of 52 patients receiving allogeneic SCT for relapsed disease. Histologies were PTCL-not-otherwise specified (n=23), anaplastic large-cell lymphoma (n=11), angioimmunoblastic T-cell lymphomas (n=9) and rare subtypes (n=9). Patients were allografted from related siblings (n=33, 64%) or alternative donors (n=13 (25%) from unrelated and 6 (11%) from haploidentical family donors), following reduced-intensity conditioning (RIC) regimens including thiotepa, fludarabine and cyclophosphamide. Most of the patients had chemosensitive disease (n=39, 75%) and 27 (52%) failed a previous autoSCT. At a median follow-up of 67 months, 27 of 52 patients were found to be alive (52%) and 25 (48%) were dead (n=19 disease progression, n=6 non-relapse mortality (NRM)). The cumulative incidence (CI) of NRM was 12% at 5 years. Extensive chronic graft-versus-host disease increased the risk of NRM (33% versus 8%, P=0.04). The CI of relapse was 49% at 5 years, influenced by disease status at the time of allografting (P=0.0009) and treatment lines (P=0.007). Five-year overall survival and progression-free survival (PFS) were 50% (95% CI, 36 – 63%) and 40% (95% CI, 27 – 53%), respectively. The current PFS was 44% (95% CI, 30–57%). In all, 8 out of 12 patients (66%) who received donor-lymphocytes infusions for disease progression had a response. At multivariable analysis, refractory disease and age over 45 years were independent adverse prognostic factors. RIC allogeneic SCT is an effective salvage treatment with a better outcome for younger patients with chemosensitive disease." @default.
• W2007180939 created "2016-06-24" @default.
• W2007180939 creator A5005558035 @default.
• W2007180939 creator A5015023141 @default.
• W2007180939 creator A5026667594 @default.
• W2007180939 creator A5038143009 @default.
• W2007180939 creator A5040329440 @default.
• W2007180939 creator A5048553220 @default.
• W2007180939 creator A5055401685 @default.
• W2007180939 creator A5057333997 @default.
• W2007180939 creator A5057806356 @default.
• W2007180939 creator A5073352185 @default.
• W2007180939 creator A5079770116 @default.
• W2007180939 creator A5082453515 @default.
• W2007180939 creator A5082571019 @default.
• W2007180939 creator A5084906998 @default.
• W2007180939 creator A5089924339 @default.
• W2007180939 date "2011-09-09" @default.
• W2007180939 modified "2023-10-14" @default.
• W2007180939 title "Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect" @default.
• W2007180939 cites W1912693401 @default.
• W2007180939 cites W1995090169 @default.
• W2007180939 cites W2014665241 @default.
• W2007180939 cites W2020347902 @default.
• W2007180939 cites W2023739525 @default.
• W2007180939 cites W2042997234 @default.
• W2007180939 cites W2055952037 @default.
• W2007180939 cites W2064575538 @default.
• W2007180939 cites W2073140442 @default.
• W2007180939 cites W2083560922 @default.
• W2007180939 cites W2099059207 @default.
• W2007180939 cites W2104553892 @default.
• W2007180939 cites W2109686908 @default.
• W2007180939 cites W2130410326 @default.
• W2007180939 cites W2131064046 @default.
• W2007180939 cites W2140253250 @default.
• W2007180939 cites W2155112288 @default.
• W2007180939 cites W2158739966 @default.
• W2007180939 cites W2162389158 @default.
• W2007180939 cites W2169574298 @default.
• W2007180939 cites W2329577198 @default.
• W2007180939 cites W2416844197 @default.
• W2007180939 doi "https://doi.org/10.1038/leu.2011.240" @default.
• W2007180939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21904377" @default.
• W2007180939 hasPublicationYear "2011" @default.
• W2007180939 type Work @default.
• W2007180939 sameAs 2007180939 @default.
• W2007180939 citedByCount "118" @default.
• W2007180939 countsByYear W20071809392012 @default.
• W2007180939 countsByYear W20071809392013 @default.
• W2007180939 countsByYear W20071809392014 @default.
• W2007180939 countsByYear W20071809392015 @default.
• W2007180939 countsByYear W20071809392016 @default.
• W2007180939 countsByYear W20071809392017 @default.
• W2007180939 countsByYear W20071809392018 @default.
• W2007180939 countsByYear W20071809392019 @default.
• W2007180939 countsByYear W20071809392020 @default.
• W2007180939 countsByYear W20071809392021 @default.
• W2007180939 countsByYear W20071809392022 @default.
• W2007180939 countsByYear W20071809392023 @default.
• W2007180939 crossrefType "journal-article" @default.
• W2007180939 hasAuthorship W2007180939A5005558035 @default.
• W2007180939 hasAuthorship W2007180939A5015023141 @default.
• W2007180939 hasAuthorship W2007180939A5026667594 @default.
• W2007180939 hasAuthorship W2007180939A5038143009 @default.
• W2007180939 hasAuthorship W2007180939A5040329440 @default.
• W2007180939 hasAuthorship W2007180939A5048553220 @default.
• W2007180939 hasAuthorship W2007180939A5055401685 @default.
• W2007180939 hasAuthorship W2007180939A5057333997 @default.
• W2007180939 hasAuthorship W2007180939A5057806356 @default.
• W2007180939 hasAuthorship W2007180939A5073352185 @default.
• W2007180939 hasAuthorship W2007180939A5079770116 @default.
• W2007180939 hasAuthorship W2007180939A5082453515 @default.
• W2007180939 hasAuthorship W2007180939A5082571019 @default.
• W2007180939 hasAuthorship W2007180939A5084906998 @default.
• W2007180939 hasAuthorship W2007180939A5089924339 @default.
• W2007180939 hasBestOaLocation W20071809392 @default.
• W2007180939 hasConcept C126322002 @default.
• W2007180939 hasConcept C141071460 @default.
• W2007180939 hasConcept C143998085 @default.
• W2007180939 hasConcept C2776694085 @default.
• W2007180939 hasConcept C2776755627 @default.
• W2007180939 hasConcept C2779263901 @default.
• W2007180939 hasConcept C2779338263 @default.
• W2007180939 hasConcept C2779695342 @default.
• W2007180939 hasConcept C2779968505 @default.
• W2007180939 hasConcept C2779972918 @default.
• W2007180939 hasConcept C2911091166 @default.
• W2007180939 hasConcept C71924100 @default.
• W2007180939 hasConcept C88879693 @default.
• W2007180939 hasConcept C90924648 @default.
• W2007180939 hasConceptScore W2007180939C126322002 @default.
• W2007180939 hasConceptScore W2007180939C141071460 @default.
• W2007180939 hasConceptScore W2007180939C143998085 @default.
• W2007180939 hasConceptScore W2007180939C2776694085 @default.
• W2007180939 hasConceptScore W2007180939C2776755627 @default.
• W2007180939 hasConceptScore W2007180939C2779263901 @default.
• W2007180939 hasConceptScore W2007180939C2779338263 @default.

• next